{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:43:43Z","timestamp":1769831023701,"version":"3.49.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151828","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T13:31:02Z","timestamp":1458653462000},"page":"e0151828","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C"],"prefix":"10.1371","volume":"11","author":[{"given":"Seiichi","family":"Tawara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaharu","family":"Iio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizou","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Shigekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Hikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Sakamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"HB El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"9401","key":"ref2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"T Poynard","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"SJ Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00535-011-0403-0","article-title":"The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan","volume":"46","author":"T Oze","year":"2011","journal-title":"J Gastroenterol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1440-1746.2003.02930.x","article-title":"Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C","volume":"18","author":"K Patel","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0009-9120(92)90150-Q","article-title":"Clinical significance of serum 7S collagen in various liver diseases","volume":"25","author":"S Yamada","year":"1992","journal-title":"Clin Biochem"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.1840040505","article-title":"The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease","volume":"4","author":"A Frei","year":"1984","journal-title":"Hepatology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"ZH Lin","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"RK Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"9262","key":"ref10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"F Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00535-013-0914-y","article-title":"Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients","volume":"49","author":"N Tamaki","year":"2014","journal-title":"J Gastroenterol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/jb\/mvn011","article-title":"Biological function of fucosylation in cancer biology","volume":"143","author":"E Miyoshi","year":"2008","journal-title":"J Biochem"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ijc.21728","article-title":"Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation","volume":"118","author":"N Okuyama","year":"2006","journal-title":"Int J Cancer"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"e66328","DOI":"10.1371\/journal.pone.0066328","article-title":"Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis","volume":"8","author":"Y Kamada","year":"2013","journal-title":"PLoS One"},{"key":"ref15","article-title":"Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis","author":"Y Kamada","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","article-title":"New Inuyama classification; new criteria for histological assessment of chronic hepatitis","volume":"6","author":"F Ichida","year":"1996","journal-title":"International Hepatology Communications"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbrc.2008.10.061","article-title":"Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells","volume":"377","author":"M Narisada","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"CT Wai","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy","volume":"131","author":"H Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"issue":"7\u20139","key":"ref20","first-page":"551","article-title":"90K (Mac-2 BP) and galectins in tumor progression and metastasis","volume":"19","author":"A Grassadonia","year":"2004","journal-title":"Glycoconj J"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","article-title":"Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin","volume":"17","author":"T Sasaki","year":"1998","journal-title":"EMBO J"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"GM Lauer","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"S Cooper","year":"1999","journal-title":"Immunity"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/cncr.10899","article-title":"Expression and immunogenicity of a tumor-associated antigen, 90K\/Mac-2 binding protein, in lung carcinoma","volume":"95","author":"Y Ozaki","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/etm.2012.768","article-title":"Expression and significance of 90K\/Mac-2BP in prostate cancer","volume":"5","author":"J Hu","year":"2013","journal-title":"Exp Ther Med"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/08923970802278177","article-title":"Serum 90K\/Mac-2 binding protein (Mac-2BP) as a response predictor to peginterferon and ribavirin combined treatment in HCV chronic patients","volume":"30","author":"PA Iacovazzi","year":"2008","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bbagen.2007.05.006","article-title":"Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis","volume":"1770","author":"M Przyby\u0142o","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","article-title":"A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis","volume":"50","author":"T Toshima","year":"2015","journal-title":"J Gastroenterol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"K Yamasaki","year":"2014","journal-title":"Hepatology"},{"key":"ref30","article-title":"Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease","author":"M Abe","year":"2014","journal-title":"J Gastroenterol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/gut.2003.026393","article-title":"Fibrosis progression in chronic hepatitis C virus infection","volume":"53","author":"GW McCaughan","year":"2004","journal-title":"Gut"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/MCG.0b013e31818be17c","article-title":"Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients","volume":"43","author":"SX Hu","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"19","key":"ref33","first-page":"4530","article-title":"Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion","volume":"56","author":"H Inohara","year":"1996","journal-title":"Cancer Res"},{"issue":"40","key":"ref34","doi-asserted-by":"crossref","first-page":"29797","DOI":"10.1074\/jbc.M605697200","article-title":"Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts","volume":"281","author":"T Nakagawa","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00535-010-0293-6","article-title":"Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus","volume":"46","author":"M Tateyama","year":"2011","journal-title":"J Gastroenterol"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.26442","article-title":"\u03b1-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C","volume":"58","author":"Y Asahina","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jgh.12915","article-title":"Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection","volume":"30","author":"H Toyoda","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/cclm-2014-0427","article-title":"Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development","volume":"53","author":"H Asazawa","year":"2015","journal-title":"Clin Chem Lab Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T17:49:29Z","timestamp":1567705769000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151828"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151828","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}